ClinicalTrials.Veeva

Menu

A Prospective Randomized Controlled Multicenter Trial of Delayed Gastric Emptying (DGE) After Pancreaticoduodenectomy Evaluating by Gastrointestinal Reconstruction

K

Kobe University

Status and phase

Unknown
Phase 3

Conditions

Postprocedural Delayed Gastric Emptying

Treatments

Procedure: Antecolic gastro- or duodeno- jejunostomy in the pancreaticoduodenectomy
Procedure: Retrocolic gastro- or duodeno- jejunostomy in hte pancreaticoduodenectomy

Study type

Interventional

Funder types

Industry

Identifiers

NCT01460550
KOPAS01

Details and patient eligibility

About

The purpose of this study is to evaluate the incidence of delayed gastric emptying in patient with pancreaticoduodenectomy between antecolic and retrocolic gastrointestinal reconstruction.

Full description

The purpose of this study is to evaluate the incidence of delayed gastric emptying in patient with pancreaticoduodenectomy between antecolic and retrocolic gastrointestinal reconstruction. Delayed gastric emptying after pancreaticoduodenectomy is important to affect the postoperative course and QOL. We conducted a prospective randomized trial on 240 patients who underwent pancreaticoduodenectomy for comparing between antecolic and retrocolic gastrointestinal reconstruction.

The primary endpoint was defined as incidence of delayed gastric emptying by ISGPS criteria. The secondary endpoint was defined as incidence of other postoperative morbidity. Patients were recruited into this study before surgery, on the basis of whether pancreatic head resection was anticipated for pancreatic head and periampullary disease, and an appropriate informed consent was obtained. Exclusion criteria was 1) patients who have the history of gastrectomy, 2) patients who have severe cardiorespiratory dysfunction, 3) patients who have liver cirrhosis or are receiving dialysis, and 4) patients who were diagnosed inadequate for this study by a physician.

Enrollment

240 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with pancreatic-biliary disease who undergo pancreaticoduodenectomy

Exclusion criteria

  • patients who have the history of gastrectomy
  • patients who have severe cardiorespiratory dysfunction
  • patients who have liver cirrhosis or are receiving dialysis
  • patients who were diagnosed inadequacy for this study by a physician

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

240 participants in 1 patient group

gastrointestinal reconstruction
Experimental group
Treatment:
Procedure: Antecolic gastro- or duodeno- jejunostomy in the pancreaticoduodenectomy
Procedure: Retrocolic gastro- or duodeno- jejunostomy in hte pancreaticoduodenectomy

Trial contacts and locations

1

Loading...

Central trial contact

Ippei Matsumoto, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems